Patent intelligence · HK
HK 1249412
PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF
PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF
Patent details — HK 1249412
- Jurisdiction
- HK
- Status
- granted
- Grant date
- Nov 2, 2018
- Expiration
- Oct 28, 2038
- Applicant
- ALK ABELLO AS
- CPC classes
- A61K/35646, A61K/3935, A61P/3708
Quick answer
HK 1249412 (PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF) is held by ALK ABELLO AS. Status: granted. Granted Nov 2, 2018. Expires Oct 28, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ALK ABELLO AS
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K/35646, A61K/3935, A61P/3708
More from ALK ABELLO AS
Related pharmaceutical patents in our USPTO index.
-
WO 2024200854
ANTICORPS DE LIAISON AUX ALLERGÈNES APPROPRIÉS POUR TRAITER DES ALLERGIES AU POLLEN D'ARBRE
granted -
EP 4302751
ORALE DÜNNFILME MIT GERINGER WASSERAKTIVITÄT
granted -
EP 4302750
ORALE DÜNNFILME ENTHALTEND ADRENALIN
granted -
CA 3259886
DISPOSITIFS DE DÉPLACEMENT D'IGE-FCERI
granted -
WO 2023232958
INHIBITEURS DE LA KINASE DE BRUTON POUR LE TRAITEMENT D'UNE RÉACTION ALLERGIQUE SOUDAINE
granted -
CA 3255134
COMPOSITION D'ALLERGÈNE D'ARACHIDE
granted -
WO 2019224246
MÉTHODES FONDÉES SUR DES BIOMARQUEURS DESTINÉES AU TRAITEMENT D'UNE MALADIE ATOPIQUE PAR IMMUNOTHÉRAPIE
granted
Frequently asked questions
What is US patent 1249412?
HK 1249412 (PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF) is held by ALK ABELLO AS. Status: granted. Granted Nov 2, 2018. Expires Oct 28, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns HK 1249412?
ALK ABELLO AS is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does HK 1249412 expire?
Our index shows an expiration date of Oct 28, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.